Smoking Cessation Vs. Harm Reduction ------04 Former Director (1997-2003), Lars M

Total Page:16

File Type:pdf, Size:1020Kb

Smoking Cessation Vs. Harm Reduction ------04 Former Director (1997-2003), Lars M THE AMERICAN COUNCIL ON SCIENCE AND HEALTH PRESENTS Dr. Elizabeth Whelan, President ACSH, 1995 Broadway 2nd Floor, New York, NY 10023 ACSH PRESENTS Helping Smokers Quit: A Role for Smokeless Tobacco? by Kathleen Meister, M.A. for the American Council on Science and Health Based on a paper by Dr. Brad Rodu and William T. Godshall, M.P.H. Art Director: Jennifer Lee October 2006 AMERICAN COUNCIL ON SCIENCE AND HEALTH 1995 Broadway, 2nd Floor, New York, NY 10023-5860 Phone: (212) 362-7044 • Fax: (212) 362-4919 URLs: http://acsh.org • http://HealthFactsAndFears.com E-mail: [email protected] This manuscript is a position statement of the American Council on Science and Health. The author gratefully acknowledges the assis- tance of the following ACSH staff who provided critical reviews of content and perspective, especially with regard to the policy sec- TABLE OF CONTENTS tions of the report. Elizabeth M. Whelan, ScD, MPH Gilbert Ross, MD President and Founder Medical/Executive Director Foreword by Sally Satel, MD ------ 01 Executive Summary ------ 02 The author also gratefully acknowledges the following individuals, who provided peer reviews, critical analysis, commentary, and sug- gestions during the development of this review, and whose names Introduction ------ 02 have been listed with their permission: Cigarette Smoking: Scott D. Ballin, JD Carl V. Phillips, PhD It's Even Deadlier Than You Think ------ 03 Tobacco and Health Policy Associate Professor, University Consultant of Alberta School of Public Washington, DC Health Nicotine: Addictive But Not Deadly ------ 03 Edmonton, AB, Canada Clive Bates Smoking Cessation vs. Harm Reduction ------ 04 Former Director (1997-2003), Lars M. Ramstrom, PhD Action on Smoking and Health, Director, Institute for Tobacco UK Studies Smokeless Tobacco Products ------ 04 London, United Kingdom Stockholm, Sweden Health Effects of Smokeless Tobacco ------ 05 Ronald W. Brecher, PhD, DABT, William O. Robertson, MD C Chem Medical Director, Washington Principal, Globaltox: Toxicology Poison Center Does Switching to Smokeless Tobacco Work? ------ 06 Focused Solutions Seattle, WA Guelph, ON, Canada Health Policy Questions ------ 06 David Schottenfeld, MD Emil William Chynn, MD, FACS, Professor Emeritus, School of MBA Public Health, University of Conclusions and Recommendations ------ 08 Medical Director, Michigan IWANT2020.com, Inc. Ann Arbor, MI Appendix: New York, NY Peter G. Shields, MD Examples of Smokeless Tobacco Products ------ 09 Michael Dubick, PhD Prof. Medicine/Oncology, Dir. Senior Research Cancer Genetics/Epidemiology, Pharmacologist, US Army Georgetown Washington, DC Institute of Surgical Research San Antonio, TX Robert B. Sklaroff, MD Elkins Park, PA ACSH accepts unrestricted grants on the condition that it is solely Dwight B. Heath, PhD Department of Anthropology, Jacob Sullum responsible for the conduct of its research and the dissemination of Brown University Senior Editor, Reason its work to the public. The organization does not perform propri- Providence, RI Dallas, TX etary research, nor does it accept support from individual corpora- tions for specific research projects. All contributions to ACSH—a Rudolph J. Jaeger, PhD, DABT, David T. Sweanor, BA (Hon), publicly funded organization under Section 501(c)(3) of the REA (California) LLB Internal Revenue Code—are tax deductible. Consulting Toxicologist, Adjunct Professor of Law and Environmental Medicine Inc. Medicine, University of Ottawa Individual copies of this report are available at a cost of $5.00. Westwood, NJ Ottawa, ON, Canada Reduced prices for 10 or more copies are available upon request. Michael Kunze, DrMed John W. Waterbor, MD, DrPH Professor, Institute of Social Associate Professor of Copyright © 2006 by American Council on Science and Health, Medicine, Medical University Epidemiology, University of Inc. This book may not be reproduced in whole or in part, by Vienna Alabama at Birmingham mimeograph or any other means, without permission. Vienna, Austria Birmingham, AL FOREWORDBy Sally Satel, M.D. smokeless tobacco is far safer than cigarettes. Even mouth cancer is only about one-third to one-half as For decades, public health advocates have champi- likely with traditional chewing tobacco and moist snuff oned harm reduction for people who either can't or products as with smoking. don't want to stop taking health risks. Needle exchange is a classic example. If intravenous drug It is rare to find such a powerful cause-and-effect rela- users get clean needles, the reasoning goes, their tionship in health epidemiology as the one between risk of contracting HIV and spreading it will be snus and reduction in lung cancer incidence and mor- reduced. tality. The other best example, it turns out, is the dan- ger of cancer posed by smoking itself. Repeat: from Smoking is another dangerous addiction. While there smoking, not from nicotine per se. is no denying that public education has done some good, more than 40 million Americans continue to Public health experts have for years endorsed harm smoke. We must face the fact that a smoke-free coun- reduction as a pragmatic last resort for hard-core sub- try is a pipe-dream. stance users. For heroin they advocate needle exchange and even supervised distribution of heroin So what about harm-reduction for committed smok- itself. For problem drinkers they have suggested ers? Unfortunately, the smoking-cessation lobby drinking in moderation. In Seattle, new public housing wants nothing to do with it. Its “experts” insist on programs for homeless alcoholics allow drinking in pushing a quit-or-die philosophy even in the face of the privacy and safety of their own apartments – a overwhelming evidence that there already exists a controversial move that is based on the tenet of harm life-saving alternative to cigarettes: smokeless tobac- reduction: that relative safety can accrue to the user co. and society even if he or she does not relinquish an addiction. The safest types are modern products like snus, or Swedish moist snuff, and a host of similar products It is ironic that much of the public health community available in the U.S. Crucially, they satisfy smokers' accepts such radical accommodations for people nicotine addiction and cause negligible health risks of addicted to intoxicants but resists the use of smoke- their own. All of these products are held discreetly less tobacco to treat an addiction that afflicts a far between lip and gum, releasing nicotine, and because greater percentage – and causes far more suffering they do not stimulate saliva production there is no from disease and death. spitting. Significantly, the blood levels of nicotine obtained with smokeless are higher than those asso- In documenting the evidence on the relative benefits ciated with gum or a patch; this is why smokeless has of smokeless tobacco as compared to smoking, this such a powerful anti-craving effect. report serves another invaluable function: It makes the powerful case that most of what people believe Even better, there is no smoke. they know about the product is outdated, wrong or both. Lamentably, the public has been subject to a And this is key. Tobacco smoke, with its thousands of vast miasma of misinformation, generated, some- toxic agents, can lead to cancer, heart disease and times deliberately, by anti-tobacco zealots and, per- emphysema. Eliminate the smoke, and you signifi- haps unwittingly, by the U.S. Department of Health cantly reduce the risk. To put it bluntly: it's the smoke, and Human Services. stupid. Reducing the harm from cigarettes depends on This comprehensive and indispensable monograph responsible science. One can ponder the political from The American Council on Science and Health agendas driving the anti-smokeless lobby, but what- presents the latest epidemiological findings on ever their motives, distorting the truth about smoke- smokeless tobacco and offers wise policy recommen- less tobacco is a grave disservice to millions of dations. The authors draw on an impressive archive American smokers. This clearly written and exhaus- of Swedish data, which is both long-ranging and tively researched monograph is a potent antidote to much-replicated. bad science and a life-saving prescription in itself. Although 40% of Swedish men use tobacco products, the same rate for men in the other 14 countries in the Dr. Satel, a psychiatrist, is a resident scholar at the European Union, Sweden has the lowest rate of lung American Enterprise Institute. She is a widely-pub- cancer by far. Why? Largely because of snus. What’s lished expert in addiction and harm reduction. more, over 20 epidemiological studies show that 1 EXECUTIVE SUMMARY According to the Centers for Disease Control and modern smokeless tobacco products. It reviews Prevention, about 45 million Americans continue to the epidemiologic evidence for low health risks smoke, even after one of the most intense public associated with smokeless use, both in absolute health campaigns in history, now over 40 years old. terms and in comparison to the much higher risks Each year some 438,000 smokers die from smok- of smoking. The report also describes evidence ing-related diseases, including lung and other can- that smokeless tobacco has served as an effective cers, cardiovascular disorders, and pulmonary dis- substitute for cigarettes among Swedish men, who eases. consequently have among the lowest smoking- related mortality rates in the developed world. The Many smokers are unable – or at least unwilling – report documents the fact
Recommended publications
  • The Health Disparities Myth: Diagnosing the Treatment
    The Health Disparities Myth The Health Disparities Myth Diagnosing the Treatment Gap Jonathan Klick, PhD, JD Sally Satel, MD The AEI Press Publisher for the American Enterprise Institute W ASHINGTON, D.C. Distributed to the Trade by National Book Network, 15200 NBN Way, Blue Ridge Summit, PA 17214. To order call toll free 1-800-462-6420 or 1-717- 794-3800. For all other inquiries please contact the AEI Press, 1150 Seventeenth Street, NW, Washington, DC 20036 or call 1-800-862-5801. Library of Congress Cataloging-in-Publication Data Klick, Jonathan. The health disparities myth : diagnosing the treatment gap / Jonathan Klick, Sally Satel. p. cm. Includes bibliographical references. ISBN-10 0-8447-7192-9 (pbk: alk. paper) ISBN-13 978-0-8447-7192-2 1. Health services accessibility—United States. 2. Medical care— Needs assessment—United States. 3. Medical policy—Social aspects— United States. I. Satel, Sally L. II. Title. [DNLM: 1. Delivery of Health Care—ethics. 2. Ethnic Groups. 3. Health Status. 4. Physician-Patient Relations. 5. Prejudice. 6. Race Relations. WA 300 K65h 2006] RA418.3.U6K65 2006 362.1089—dc22 2005034903 10 09 08 07 06 2 3 4 5 © 2006 by the American Enterprise Institute for Public Policy Research, Washington, D.C. All rights reserved. No part of this publication may be used or reproduced in any manner whatsoever without permission in writing from the American Enterprise Institute except in the case of brief quotations embodied in news articles, critical articles, or reviews. The views expressed in the publications of the American Enterprise Institute are those of the authors and do not necessarily reflect the views of the staff, advisory panels, officers, or trustees of AEI.
    [Show full text]
  • Enterprise Report Restoring Liberty, Opportunity, and Enterprise in America
    Issue No. 1, Winter 2021 Enterprise Report Restoring Liberty, Opportunity, and Enterprise in America AEI Today, Five Days a Week By Robert Doar My favorite time of day is the 30 minutes before 6:00 a.m. when I drink coffee with my wife, Sara, and discuss what we are reading on our laptops. This easy time is punctuated when AEI Today pops into our inboxes. AEI Today is not predictable. Our scholars share certain values for sure, but they cover so much territory and offer such different approaches that you never can be quite sure what you are going to get on any morning: a pathbreaking research paper, yes; a hard-hitting op-ed in a prominent newspaper, yes; a thoughtful blog on an underappreciated issue, yes as well. Take the February 17 edition: Among the 38 items featured that day were peer-reviewed papers, AEI reports, blog posts, podcasts, a video, and op-eds in a wide variety of outlets, including the Wall Street Journal and Los Angeles Times. Each piece was grounded in facts and empirical data and presented new informa- tion and ideas you don’t get anywhere else. Some responded to the news of the day, and others took a long-term view of world events and trends. This variety and depth is presented without tribal cant or partisan cheerleading, an increasingly rare commodity in a polarized media environment—except at AEI. Just a few highlights from that day: • A major report titled China, Unquarantined from Dan Blumenthal and Nicholas Eberstadt, underscoring the catastrophic consequences of setting the Chinese Communist Party loose in
    [Show full text]
  • Health Care Disparities
    U.S. Commission on Civil Rights The U.S. Commission on Civil Rights is an independent, bipartisan agency established by Congress in 1957. It is directed to Investigate complaints alleging that citizens are being deprived of their right to vote by reason of their race, color, religion, sex, age, disability, or national origin, or by reason of fraudulent practices. Study and collect information relating to discrimination or a denial of equal protection of the laws under the Constitution because of race, color, religion, sex, age, disability, or national origin, or in the administration of justice. Appraise federal laws and policies with respect to discrimination or denial of equal protection of the laws because of race, color, religion, sex, age, disability, or national origin, or in the administration of justice. Serve as a national clearinghouse for information in respect to discrimination or denial of equal protection of the laws because of race, color, religion, sex, age, disability, or national origin. Submit reports, findings, and recommendations to the President and Congress. Issue public service announcements to discourage discrimination or denial of equal protection of the laws. Members of the Commission Gerald A. Reynolds, Chairman Abigail Thernstrom, Vice Chair Todd Gaziano Gail Heriot Peter N. Kirsanow Arlan D. Melendez Ashley L. Taylor, Jr. Michael Yaki Martin Dannenfelser, Staff Director U.S. Commission on Civil Rights 624 Ninth Street, NW Washington, DC 20425 (202) 376-8128 (202) 376-8116 TTY www.usccr.gov This report is available on disk in ASCII Text and Microsoft Word 2003 for persons with visual impairments. Please call (202) 376-8110.
    [Show full text]
  • Lennard J. Davis (Ed.)-The Disability Studies Reader-Routledge
    The Disability Studies Reader The Fourth Edition of the Disability Studies Reader breaks new ground by emphasiz- ing the global, transgender, homonational, and post-human conceptions of disability. Including physical disabilities, but exploring issues around pain, mental disability, and invisible disabilities, this edition explores more varieties of bodily and mental experi- ence. New histories of the legal, social, and cultural give a broader picture of disability than ever before. Now available for the first time in eBook format. Lennard J. Davis is Professor of Disability and Human Development, English, and Medi- cal Education at the University of Illinois at Chicago. He is the author of, among other works, Enforcing Normalcy: Disability, Deafness, and the Body; Bending Over Backwards: Disability, Dismodernism, and Other Difficult Positions; My Sense of Silence: Memoirs of a Childhood with Deafness; and Obsession: A History. The Disability Studies Reader Fourth Edition Lennard J. Davis First published 2013 by Routledge 711 Third Avenue, New York, NY 10017 Simultaneously published in the UK by Routledge 2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN Routledge is an imprint of the Taylor & Francis Group, an informa business © 2013 Taylor & Francis The right of the editor to be identified as the author of the editorial material, and of the authors for their individual chapters, has been asserted in accordance with sections 77 and 78 of the Copyright, Designs and Patents Act 1988. All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers.
    [Show full text]
  • Satel Altruism PR Jan Final.Qxd
    Media inquiries: Véronique Rodman 202.862.4870 ([email protected]) Orders: 800.462.6420 or www.aei.org/books COMPENSATING ORGAN DONORS COULD SAVE THOUSANDS OF LIVES When Altruism Isn’t Enough: The Case For Compensating Kidney Donors Edited by Sally Satel, MD FOR IMMEDIATE RELEASE: January 2009 America faces a desperate organ shortage. Today, more than 78,000 people are waiting for a kid- ney transplant; only one in four will receive one this year, while twelve die each day waiting for help. Not surprisingly, many patients are driven to desperate measures to circumvent the eight-year waiting list—renting billboards, advertising in newsletters, or even purchasing organs on the global black market. Altruism is an admirable but clearly insufficient motivation for would-be donors. The AEI Press What can be done to solve the kidney crisis? Reward people who donate their organs. Compen- sating people who donate to a desperate stranger will motivate others to do the same, increase the national supply of kidneys, and reduce needless death and suffering. When Altruism Isn’t Enough: The Case for Compensating Kidney Donors (AEI Press, January 2009) argues for a government- regulated system in which prospective donors are offered economic incentives to donate a kidney. It is the first book to explore how a government-regulated, compensation-based system for living donors could be designed. When Altruism Isn’t Enough shows why compensating donors is ethically permissible, economically justifiable, and pragmatically achievable. Dr. Satel and her colleagues call on Congress to reform the 1984 National Organ Transplant Act (NOTA), which makes it a felony to provide material reward for an organ.
    [Show full text]
  • When Altruism Isnt Enough
    When Altruism Isn’t Enough When Altruism Isn’t Enough The Case for Compensating Kidney Donors Edited by Sally Satel, MD The AEI Press Publisher for the American Enterprise Institute WASHINGTON, D.C. Distributed to the Trade by National Book Network, 15200 NBN Way, Blue Ridge Summit, PA 17214. To order call toll free 1-800-462-6420 or 1-717-794-3800. For all other inquiries please contact the AEI Press, 1150 Seventeenth Street, N.W., Washington, D.C. 20036 or call 1-800-862-5801. Library of Congress Cataloging-in-Publication Data When altruism isn’t enough : the case for compensating kidney donors / edited by Sally Satel. p. ; cm. Includes bibliographical references. ISBN-13: 978-0-8447-4266-3 ISBN-10: 0-8447-4266-X 1. Kidneys—Transplantation—Economic aspects. I. Satel, Sally L. [DNLM: 1. Kidney Transplantation—economics. 2. Kidney Transplantation— ethics. 3. Tissue Donors—ethics. WJ 368 W567 2008] RD575.W54 2008 617.4'610592—dc22 2008045715 12 11 10 09 08 1 2 3 4 5 © 2008 by the American Enterprise Institute for Public Policy Research, Washington, D.C. All rights reserved. No part of this publication may be used or reproduced in any manner whatsoever without permission in writing from the American Enterprise Institute except in the case of brief quotations embodied in news articles, critical articles, or reviews. The views expressed in the publications of the American Enterprise Institute are those of the authors and do not necessarily reflect the views of the staff, advisory panels, officers, or trustees of AEI. Printed in the United States of America To Virginia and Steve Postrel Contents LIST OF ILLUSTRATIONS xi ACKNOWLEDGMENTS xiii INTRODUCTION, Sally Satel 1 Death and Suffering Mount 2 Altruism Isn’t Enough 3 The Advantages of Living Donors 4 Compensation for Living Kidney Donors 6 Calling on Congress 8 1.
    [Show full text]